| ²é¿´: 1125 | »Ø¸´: 2 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
ÃÀ¹úÓÌËû´óѧ·Ö×ÓÓ°ÏñºÍÉúÎï²ÄÁÏ·½ÏòÕÐÊÕÈ«¶î½±Ñ§½ð²©Ê¿ºóÒÔ¼°²©Ê¿Ñо¿Éú
|
|||
|
ÃÀ¹úÓÌËû´óѧÊÇÃÀ¹úÓÌËûÖݵĸߵȽÌÓýÆì½¢ÐÍ´óѧ£¬Ò²ÊÇÒ»ËùÊÀ½ç¶¥¼âµÄ¹«Á¢Ñо¿ÐÍ´óѧ£¬ ÊôÓÚ±±ÃÀ¶¥¼¶Ñо¿ÐÍ´óѧÁªÃËÃÀ¹ú´óѧлᣨAAU£©¡¢Ì«Æ½ÑóÊ®¶þУÁªÃË£¨PAC-12£©³ÉÔ±£¬ÎªÌظßÑо¿ÐÍ´óѧ£¨Top-tier Research university£©¡£2025U.S. NewsÃÀ¹ú×î¼Ñ¹«Á¢´óѧÅÅÃûµÚ69룬2024WRWUÊÀ½ç´óѧÅÅÃûµÚ65룬 2024Èí¿ÆÊÀ½ç´óѧѧÊõÅÅÃûµÚ101-150£¬ ¿ÉÈëѧҩѧԺ2025U.S. NewsÃÀ¹úרҵÅÅÃûÈ«ÃÀµÚ26λ¡£ Dr. Shi¹²·¢±í40ÓàÆªÎÄÕ£¨ÒýÓÃ>4735, HÒò×Ó33£©£¬°üÀ¨ ACS Nano, Angewandte Chemie, Biomaterials, JNM, Nature NanotechnologyµÈ±¾ÁìÓò¶¥¼¶ÆÚ¿¯¡£µ£ÈÎJournal of Nanobiotechnology£¨IF=10.6)¸±Ö÷±à£¬²¢»ñµÃ SNMMI Ones to Watch 2020µÈÖî¶àÈÙÓþ¡£±¾ÊµÑéÊÒѧÉú/²©Ê¿ºó´ó¶à¶¼ÔÚµÚÒ»Äê/µÚ¶þÄê»ñµÃÁËÓÅÐãѧÉú½±Ñ§½ð¡¢¹ú¼Ê»áÒéǽ±¨½±µÈÓÅÒì³É¼¨£¬ÆÚ´ýеÄѧÉú/²©Ê¿ºó¼ÓÈë¼ÌÐøÊµÑéÊÒµÄÓÅÐã¼Í¼¡£ ÕÐÉúÒªÇó£º 1. ·Ö×ÓÓ°Ïñ¡¢ÉúÎï¡¢»¯Ñ§¡¢²ÄÁϵÈÏà¹Ø±³¾°µÄ²©Ê¿¡¢Ë¶Ê¿¡¢±¾¿Æ×îºóÒ»ÄêÓ¦½ìÉú¡£ 2. ѧϰ³É¼¨ÓÅÒ죬ÓÐ×êÑо«Éñ¡£ÓпÆÑоÀúºÍÂÛÎÄ·¢±íÕßÓÅÏÈ¡£ 3. ÓÐÁ¼ºÃµÄÓ¢ÎÄ»ù´¡£¬´ïµ½Íи£80·Ö»òÕßÑÅ˼6.5·Ö¡£ н×Ê´ýÓö£º ²©Ê¿ºó£ºNIH¹¤×ʺ͸£Àû ²©Ê¿Ñо¿Éú£ºÈ«¶î½±Ñ§½ð£¨RA) ÓÐÒâÕßÇëÁªÏµsixiang.shi@utah.edu ʵÑéÊÒÍøÖ·£ºhttps://www.miniresearchlabs.net/ ¾ßÌåÕÐÉúÐÅÏ¢ÈçÏ£º Open Positions at the MINILabs at University of Utah -- PI Dr. Sixiang Shi The Molecular Imaging and Nanotechnology Innovation Laboratory (MINILabs) is seeking graduate students, postdoctoral fellows, and visiting scholars to lead research efforts at the intersection of molecular imaging and nanomedicine. Our core mission is to revolutionize the way we visualize, understand and treat cancer and other diseases, by potentiating simple but powerful solutions to biomedical and healthcare challenges. Laboratory Research Directions: 1. Application of advanced molecular imaging techniques (PET/CT, optics, optoacoustic imaging, etc.) in cancer, regenerative medicine and other diseases; 2. Development of innovative nanomedicine and natural biomaterials for personalized theranostics; 3. Development of novel radiochemistry and targeted radiotherapy for refractory diseases; 4. Utilizing advanced imaging tools to understand the biological unknowns in tumor microenvironment, metastasis, immunology, etc. Trainees will be a part of a highly multidisciplinary and collaborative group within the Department of Radiology and Imaging Sciences and the Department of Molecular Pharmaceutics at the University of Utah, led jointly by PIs Dr. Shi and Dr. Goel. The excellent academic environment at the University of Utah offers excellent career development and enhancement opportunities at all levels. Applicant Requirements: 1. Familiarity with advanced techniques in molecular biology, biomedical imaging and biomaterials research is preferred. 2. Successful candidates will be motivated, curious and independent thinkers with a strong sense of responsibility and good oral and written communication skills. 3. Applicants should be final-year PhD/masters/4th-year undergraduate students. 4. The students exhibiting outstanding performance with excellent GPA and research track record will be given preference. 5. The international students must successfully complete the English Proficiency Test (TOEFL 80 or IELTS 6.5). 6. Applicants for postdoctoral fellows with outstanding publication record and ability to work independently will be given priority. Contact: Interested candidates are recommended to send their CVs to Dr. Sixiang Shi (sixiang.shi@utah.edu). Principal Investigator (PI): Dr. Sixiang Shi received his PhD degree in Materials Science and Engineering from the University of Wisconsin-Madison in 2016 and completed his postdoctoral fellowship from MD Anderson Cancer Center in 2020. He shortly worked in the Department of Health Technology and Informatics at the Hong Kong Polytechnic University as an Assistant Professor in 2021. He joined the Department of Radiology and Imaging Sciences at the University of Utah in August 2022. So far, he has published >40 papers (>4735 citations, h-index: 33), in top journals such as ACS Nano, Angewandte Chemie, Biomaterials, JNM, Nature Nanotechnology, among others. Dr. Shi serves as Associate Editor for Journal of Nanobiotechnology, Editorial Member for Journal of Functional Biomaterials, and reviewer for more than 20 journals, scientific societies, grants agencies and conferences. Dr. Shi has received multiple awards and honors for his research and scholarship, including the SNMMI Ones to Watch 2020, which recognizes most promising researchers worldwide in the fields of nuclear medicine and molecular imaging. Details can be found via https://www.miniresearchlabs.net/ |
» ²ÂÄãϲ»¶
²ÄÁϵ÷¼Á
ÒѾÓÐ6È˻ظ´
2026É격×Ô¼ö Áù¼¶440µç´ß»¯·½Ïò
ÒѾÓÐ3È˻ظ´
»¶Ó211±¾¿ÆÍ¬Ñ§£¬¹ýAÇø¹ú¼ÒÏߣ¬AÇø·ÇƫԶһ±¾£¬½»²æÑ§¿Æ¿ÎÌâ×é
ÒѾÓÐ24È˻ظ´
н®´óѧµØÖÊÓë¿óÒµ¹¤³ÌѧԺÕÐÉú
ÒѾÓÐ10È˻ظ´
Õе÷¼Á
ÒѾÓÐ11È˻ظ´
0856²ÄÁÏÓ뻯¹¤Çóµ÷¼Á£¡
ÒѾÓÐ11È˻ظ´
²ÄÁÏÓ뻯¹¤304Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
AÇøÒ»±¾½»²æ¿ÎÌâ×飬µÍ·Öµ÷¼Á£¬ÕÐÊÕ»úеµç×ÓÐÅϢͨÐŵȽ»²æ·½Ïò
ÒѾÓÐ31È˻ظ´
Öпƴó²ÄÁÏ299Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
Öйúũҵ¿ÆÑ§Ôº»··¢Ëù²©Ê¿ºóÕÐÆ¸
+2/436
½Î÷ʦ·¶´óѧÌն˽¡½ÌÊÚÍŶÓ2026Äê˶ʿÑо¿ÉúÕÐÉú¹«¸æ
+1/231
ÕÐÆ¸¿ÆÑÐÖúÀí
+1/175
¶«ÄÏ´óѧÂÞÐÛ½£¿ÎÌâ×éÕÐÆ¸ÆôÊÂ
+2/136
°²»Õũҵ´óѧÀîÑǻԽÌÊÚÕÐÊÕÉúÎï¡¢»¯Ñ§¡¢Å©Ò©Ñ§¡¢Ö²±£Àà2026¼¶²©Ê¿Ñо¿Éú
+1/82
°¬Àï¿¨ÌØ (Alicat) ±¾°²ia·À±¬ÐÍÖÊÁ¿Á÷Á¿¿ØÖÆÆ÷Ó¦ÓÃÓÚµç½âÖÆÇâ
+2/50
ÖйúÒ½¿Æ´óѧÓÚÒÕ±ó¿ÎÌâ×é³ÏÕÐÑо¿ÉúÒÔ¼°µ÷¼ÁÉú
+1/35
ÕÐÏÍÄÉ˶-±±¾©»¯¹¤´óѧ»¯Ñ§Ñ§ÔºÕÐÊյ绯ѧºÍ×ÊÔ´»¯Ñ§·½ÏòÐÂÔö˶ʿÉú1Ãû
+1/33
ÖйúʯÓÍ´óѧ£¨±±¾©£©¹ú¼Ò¼¶´óÈ˲ÅÍŶӲ©Ê¿ÕÐÉú3Ãû£º»¯Ñ§¡¢²ÄÁÏ¡¢Ê¯Ó͹¤³Ì£ºÓÍÌﻯѧ
+1/32
ÃÀ¹úÃÜËÕÀï´óѧ¡°ÈáÐÔµç×Ó¡±¿ÎÌâ×é³ÏƸ²©Ê¿ºÍ²©Ê¿ºó
+1/23
ÄϾ©ÁÖÒµ´óѧ-¹ú¼Ò¼¶ÇàÄêÈ˲ÅÍÅ¶Ó ÕÐ2026¼¶ÉêÇ뿼ºËÖÆ²©Ê¿£¨»¯Ñ§·½Ïò£©
+1/15
¡¾ÊµÕ½ÐÍ¡¿¡¾ÉúÎïÒ½Ò©¡¿2026Çൺ´óѧÕв©Ê¿Éú
+1/13
Öйú¿ÆÑ§Ôº¹ú¼Ò¼¶È˲ÅÍŶӲ©Ê¿ºóÕÐÆ¸Æôʾ
+1/11
¼ÃÄÏ´óѧ¹¢±ø·ú»¯Ñ§¿ÎÌâ×éÏÖÕÐÊÕ2026¼¶»¯Ñ§¹¤³Ìѧ˶ר˶¹²4Ãû
+1/8
°²»Õũҵ´óѧÐíÔÆ»Ô½ÌÊÚ¿ÎÌâ×éÕÐÊÕ²ÄÁÏÀà¡¢»¯¹¤ÀࡢҽѧÀàµÈ¹¤¿Æ×¨Ë¶Ñ§Ë¶¿¼Ñе÷¼Á
+1/8
°²»Õũҵ´óѧÐíÔÆ»Ô½ÌÊÚ¿ÎÌâ×éÕÐÊÕ²ÄÁÏÀà¡¢»¯¹¤ÀࡢҽѧÀàµÈ¹¤¿Æ×¨Ë¶Ñ§Ë¶¿¼Ñе÷¼Á
+1/6
¡°½ÌÓý²¿³¤½Ñ§Õߺʹ´ÐÂÍŶӷ¢Õ¹¼Æ»®¡±ÈëÑ¡ÍŶÓÕÐÊÕ²ÄÁÏ£¬»¯Ñ§Ó뻯¹¤²©Ê¿Ñо¿Éú
+1/6
-·Ö×Ó̽ÕëµÈ»¯Ñ§/ÉúÎï·½Ïò²©Ê¿ºóºÍÑо¿ÖúÀí
+1/5
26½ì¼ÆËã»ú¡¢µç×ÓÐÅÏ¢Àà¡¢µç¿Æ¡¢¿ØÖÆ¡¢Í¨ÐÅ¿¼ÑÐT jÐÅÏ¢pp¿¥£º74+08+76+6+20/
+1/4
120202ÄϾ©´óѧÆóÒµ¹ÜÀíÇóµ÷¼Á
+1/3
3Â¥2025-01-10 07:34:37













»Ø¸´´ËÂ¥
